As we have continued to identify areas of growth and new opportunities for the Health Science Center, one that keeps coming to the forefront is “Translational Research.” This is an area that allows scientific discoveries to advance into human trials with the highest possible chance of success in terms of both safety and efficacy.
Per the National Institutes of Health, “Translational Research is the process of applying knowledge from basic biology and clinical trials to techniques and tools that address critical medical needs. Unlike applied sciences, translational research is specifically designed to improve health outcomes and is often used interchangeably with bench-to-bedside.”
We are very fortunate to have this research currently taking place at the Health Science Center and I’m pleased to officially announce the formation of our “Institute for Translational Research.” This innovative new Institute will be led by Dr. Sid O’Bryant, Professor and Executive Director of the Institute for Translational Research and will occupy the entire fifth floor of the UNT Health Pavilion.
Dr. O’Bryant is currently overseeing one of the largest and most comprehensive studies ever conducted in the United States focused on Mexican-Americans and Alzheimer’s disease. This 5-year study began on September 4, 2017 and is funded by a $12 million grant from the NationalInstitutes of Health. “This is the first project to specifically focus on understanding how different biological causes relate to Alzheimer’s disease across ethnicities,” said Dr. O’Bryant. “By looking at different potential causes related to memory loss, we may be able to target the right pathway at the right time with the right intervention.”
Dr. O’Bryant’s success in Alzheimer’s research has positioned him as one of the most knowledgeable and well-funded researchers in the world as it relates to his area of expertise. He is a nationally and internationally recognized visionary who will work to leverage our strengths in Translational Research to position the Institute as the premier “Institute for Translational Research” in the world.
Please join me in congratulating Dr. O’Bryant on this exciting new opportunity and thank you for your ongoing support as we launch our new “Institute for Translational Research.”All The Best,
Charles Taylor, PharmD
Provost and Executive Vice President for Academic Affairs